Pearl River-based Pfizer and BioNTech yesterday said that they have asked the FDA to grant them emergency use authorization for their COVID-19 vaccine for children six months to five years-old. CNN reports results of a clinical trial released last week showed the vaccine appeared to be safe and had a strong immune response.